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Although  experimental  trypanosomiasis  has  been  the  subject  of 
countless  contributions  to  the  literature,  comparatively  little  has 
been written regarding the biological principles involved in the adapta- 
tion of the experimental infection to chemotherapeutic investigations. 
There  have  been  numerous  reports  dealing with  the more or  less 
successful treatment of experimental trypanosomiasis beginning with 
Laveran and  Mesnil  (1),  who showed in  1902 that  arsenite of soda 
had a marked although only a temporary beneficial effect on the course 
of flagana infections in  mice.  2  years later  Ehrlich  and  Shiga  (2) 
published  their remarkable results with trypan red with which they 
were  able  to  cure  mice  infected  with  caderas.  This  contribution 
marked the beginning of a systematic search for synthetic compounds 
which would exercise a  specific therapeutic effect upon this  class of 
infections,  but  despite  the  extensive investigations  that  have  been 
directed toward this  end during the past 15 years, the basic concepts 
underlying the  adaptation of  experimental trypanosomiasis to chem- 
otherapeutic  investigations  have  remained  rather  obscure.  The 
experimental procedure employed by different investigators has been 
of the most diverse character, yet little has come out of these years of 
experience that would aid one either to a  more judicious use of the 
material at his disposal or in the correct interpretation of therapeutic 
results  obtained.  The  available  information, such as it is,  is so dif- 
fusely scattered through the literature that it is a well-nigh impossible 
task  for one not  thoroughly conversant with  the facts  to  assemble 
it or to discriminate among the bewildering mass of statistics, reports, 
inferences, and statements with which he is at once confronted.  In 
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view of  this  situation,  we have attempted  to  present  some of  the 
salient  features  of  experimental  trypanosomiasis  together  with  an 
analysis of the biological factors underlying its adaptation to chemo- 
therapeutic investigations. 
Trypanosomiasis  in Nature. 
Trypanosomiasis comprises a  group  of widespread infectious con- 
ditions,  some form of which is found in practically all parts  of the 
world.  Both warm and  cold blooded animals are naturally suscep- 
tible  to  infection with one  or another species of the organism.  In 
some instances, it is an apparently harmless parasitic condition, while 
in others, the infection produces grave manifestations of disease.  For 
medical and  economic reasons,  the greatest interest  has  naturally 
been directed toward those forms of the disease affecting man and 
the domestic animals.  Chief among these are the human infections 
with Tr. gambiense and Tr. rhodesiense which cause the so called sleep- 
ing sickness of Africa~  and  the animal infections due to  Tr.  brucei, 
Tr. evansi, Tr. equiperdum,  Tr.  equinum,  Tr. dimorphon,  Tr. theileri, 
and Tr. congolense.  Of these organisms, Tr. brucei, which, causes the 
nagana of wild and domestic animals of Africa, Tr. dimorphon, known 
as the causative agent of Garnbian horse disease, producing a chronic 
infection in other domestic animals as well, Tr. theiIeri, the causative 
agent of galziekte or bile. fever in  cattle,  and  Tr.  congolense, which 
produces a chronic infection in horses, cattle, sheep, and dromedaries, 
are all confined to Africa.  Tr. evansi, the causative agent of surra, is 
much  more  widely  distributed,  being  found  throughout  Southern 
Asia  and  the  adjacent  islands,  as  well  as  Northern  Africa.  The 
real de caderas in horses produced by Tr. equinum is confined to cer- 
tain sections of South America, while dourine of horses produced by 
Tr. equiperdum is widely distributed through Africa, Asia, and certain 
portions of the United States, Canada, and Southern Europe. 
As  a  class,  these  diseases both  of man and  of animals  are  char- 
acterized by general constitutional disturbances such as febrile periods 
during which the infecting organisms may be present in the blood, by 
anemias, emaciation, and weakness, and by general or localized edema 
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and granulomatous and ulcerative lesions.  In most of these diseases, 
the  mortality is  extremely high,  in  some  uniformly fatal,  while  in 
others, the course of the infection is relatively mild. 
In general, the trypanosomes causing these diseases can be success- 
fully inoculated into such animals as mice, rats, guinea pigs, rabbits, 
cats, dogs, monkeys, sheep,  goats, pigs,  horses,  do~keys, mules, and 
cattle, thus affording a great variety of experimental infections capable 
of  endless  propagation.  The  ease  with  which  these  experimental 
infections may be produced is extremely variable as is the character 
of  the  resulting  infections  which  may  vary  from  an  acutely  fatal 
infection of a  few days' duration in mice to marked chronic infection 
of many months' duration in the larger animals. 
Experimental  Infections Employed  by Other Investigators. 
During  recent  years,  many of  these  experimental infections have 
found wide  application  in  the  chemotherapy  of  experimental  tryp- 
anosomiasis.  Experimental nagana has perhaps been most frequently 
employed for such purposes.  The French and German investigators 
have used mice for most of their experiments, supplemented in many 
instances by larger animals, while many of the English workers have 
selected the rat as the animal of choice for all routine work. 
Ehrlich and Shiga  (2)  used  mice infected with nagana and caderas  for the 
majority of their experiments.  Roehl (3), working with atoxyl and arsenophenyl- 
glycine in Ehrlich's laboratory, used  mice infected  with the "ferrox" strain of 
nagana for most of his experiments,  but carried  out some experiments  also on 
rabbits and guinea pigs infected with nagana and on rabbits infected with dourine. 
Schilling (4), also working with arsenophenylglycine, used nagana infections in 
mice, rats, dogs, and horses, but again the bulk of the work was done with mice. 
Browning (5) used mice infected with nagana and with dourine in testing arsacetin, 
and Morgenroth and Halberstiidter  (6) used nag~na mice. 
Laveran and Mesnil (1) in their first chemotherapeutic experiments worked with 
nagana mice.  Nicolle and Mesnil (7) in their work With the benzidine derivatives 
used  mice infected  with T'.'. brucei, Tr. evansi, and Tr. equinum.  Laveran (8) 
in his experiments with arsenious acid and trypan red used mice, rats, dogs, and 
monkeys and in working with  atoxyl, arsacetin,  arsenic  trisulfide,  and  tartar 
emetic, used guinea pigs infected with Tr. dimorphon and Tr. congolense.  More 
recently, Laveran and Roudsky (9)  in testing the activity of galyl used  eight 
strains of trypanosomes in mice and but one in guinea pigs.  Lafont and Dupont 
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with his new synthetic compounds 882 and 1021 (luargol), Danysz (11) used mice 
infected  with  Tr.  evansi,  Tr.  rhodesiense,  Tr.  gambiense,  and  Tr.  dimorphon, 
although  he  also  reports some experiments with  surra  rabbits.  Yakimoff and 
Wassilevsky (12) selected dourine mice for their experiments with luargol. 
The English investigators, Breinl and Nierenstein (13), recommend the rat as 
the animal of choice, stating that the most conclusive  evidence can be obtained 
with this animal.  Their experiments were carried out with infections produced 
by Tr.  brucei, Tr. equiperdum,  and  Tr. gambiense in rats, guinea pigs,  donkeys, 
and monkeys.  Plimmer and Thomson (14) selected  rats infected with nagana 
and surra for their work with antimony compounds.  Wenyon (15) conducted a 
long series of experiments with benzidine dyes on mice infected with Tr. dimorphon, 
and Seide]in  (16) tested the therapeutic activity of salvarsan-copper in rats in- 
fected with Tr. brucei.  On the other hand, in contrast to the somewhat limited 
procedure of many workers, Thomas and Breinl (17) in their therapeutic experi- 
ments with atoxyl and trypan red employed a considerable  number of trypanoso- 
real infections (Tr. gambiense, Tr. evansi, Tr. brucei, Tr. equinum,  Tr. equiperdum, 
and Tr. dimorphon) in practically all the common laboratory animals and contrary 
to general practice, their conclusions  regarding the efficacy of these drugs were 
based for the most part on the results obtained in the larger animals. 
In American laboratories, comparatively little has been done on the  chemo- 
therapy  of  experimental trypanosomiasis.  Rowntree  and  Abel  (18),  working 
with  compounds of antimony,  used  Tr.  brucei, Tr.  evansi, and  Tr.  dimorphon 
infections in rats, rabbits, dogs,  and one donkey, while Schamberg, Kolmer, and 
Raiziss (19) have expressed a preference for rats infected with Tr. equiperdum. 
These examples will suffice to show something of the way in which 
different  forms  of  experimental  trypanosomiasis  have  been  used  in 
chemotherapeutic  investigations.  Doubtless  each  worker  has  had 
his  own  reasons  for  using  one  or  another  of  these  experimental  in- 
fections, but, with few exceptions, little space has been devoted to the 
exposition  of  these  reasons.  The  definite  conception  of  the  clinical 
significance  of  experimental  infections  in  larger  animals  held  by 
Thomas (20)  as the basis for deductions  from his therapeutic  experi- 
ments  with  atoxyl,  raised  for  the  first  time  the  importance  of these 
factors in the ultimate determination of therapeutic efficiency.  Later 
Breinl and Nierenstein  (13) devoted considerable space to a  discussion 
of the  relative merits  of the  use  of rats in  chemotherapeutic  experi- 
ments  and  expressed  the  opinion  that  the  most  conclusive  evidence 
can  be  obtained  with  rats  as  they  are  very susceptible to infections, 
their reaction is very constant, and their relapsing time is fairly regular 
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pounds.  As  regards  the  other  animals,  they  cited  the  facts  that 
guinea  pigs  often  died  after  a  short  course  of  treatment  from  no 
apparent reason and that in the chronic infection of rabbits, parasites 
were usually present  in  exceedingly  small  numbers  and  the  clinical 
symptoms were generally easily controlled by the trypanocidal drugs. 
Further,  since mice  tolerate,  in  proportion  to  the  body weight,  im- 
mense  doses  of  different  drugs,  they  considered  it  unwise  to  draw 
general conclusions from mice experiments for the use of drugs in the 
treatment  of sleeping sickness and animal  trypanosomiasis.  Finally, 
Uhlenhuth,  Htibener,  and  Woithe  (21)  pointed  out the difference 
between such infections as those of mice and rats, in which the disease 
is largely  a  blood infection,  and  that  of rabbits,  in which  tissue in- 
volvement  is  the  conspicuous  feature,  but  apparently  made  little 
use of this fundamental principle. 
Taken  as  a  whole,  mice  have  been  much  more  extensively  used 
than  any  other  animal  and  the  infecting  organism  most  commonly 
employed has  been  Tr.  3rucei.  Next  in  frequency have  come rats, 
while guinea pigs, rabbits,  and other animals have been used in small 
numbers and largely to supplement mouse or rat experiments.  Much 
the same condition hasprevailed as regards the use of different species 
of trypanosomes.  As the matter now stands,  this diversity of usage 
is  very disconcerting  and  might  seem  to indicate  that  there  is very 
little involved in the question of the adaptation of experimental  tryp- 
anosomiasis to chemotherapeutic investigations and  that  it mattered 
but little which animal or which organisms were used for the experi- 
ments or how they were used.  As a matter of fact, this is far from the 
case and we are inclined  to interpret  this lack of any concerted plan 
of procedure as evidence of a too restricted view of the factors involved 
and, in addition,  as a need for a more critical analysis of these factors 
as  a  basis  for  the  adaptation  of the  experimental  conditions  to  the 
requirements  of  the  investigator.  That  there  are  definite  require- 
ments to be met may be self-evident, but nowhere do we find a very 
clear  statement  of  what  they  may  be.  Reduced  to  the  simplest 
terms,  the  essential  requirements  of the  worker in  chemotherapy  of 
trypanosomiasis  are  a  means  of determining  quickly and  accurately 
the activity of substances upon an infecting organism and a means of 
determining  the  curative powers of these  substances,  which,  as  will 114  EXPERIMENTAL  TRYPANOSOMIASIS 
appear  later,  may  be  problems  of  an  entirely  different  character. 
The  solution  of  these  problems  can  best  be  approached  through  a 
careful  analysis  of  the  various  forms  of  trypanosomiasis  including 
both animals and organisms that may be used, the means of propagat- 
ing and regulating  the infection,  and  finally,  the general  response of 
various species of trypanosomes to therapeutic agents. 
Experimental  Trypanosomiasis. 
Propagation of the Infection. 
The  propagation  of  experimental  trypanosomiasis  may  be  ac- 
complished  in  many  ways.  In  principle,  the  blood  of  an  infected 
animal which contains the organisms is used as the medium of trans- 
ference of the infection  from  animal  to  animal.  This  blood, drawn 
either  from a  peripheral  vessel  or  from  the  heart,  is diluted with a 
suitable  medium  such" as  isotonic  salt  solution  or  a  dilute  sodium 
citrate  solution and  the  requisite  dose of the infecting  suspension is 
introduced  into  the  next  animal,  either  subcutaneously,  intraperi- 
toneally,  or  intravenously.  The  general  scheme  of  animal  inocula- 
tion may be illustrated  by a  brief description  of the methods which 
we have employed for several years. 
For reasons which will appear later, it is advisable to maintain  the 
stock organisms in two classes of animals,  one in which the infection 
is an acute progressive blood infection as in the mouse or the rat, and 
the other in which the infection pursues a  more chronic  course such 
as the guinea pig.  Continuous direct passage from animal to animal 
of  the  same  species is  desirable  in  order  to  maintain  uniformity  of 
infection reactions where the organisms are to be used for therapeutic 
experiments.  In  transferring  stock  strains  of  trypanosomes,  the 
blood  from  a  guinea  pig  showing  a  well developed infection (micro- 
scopic examination of the blood) with actively motile and non-agglom- 
erated trypanosomes is taken from the  ear vein or heart  with  sterile 
precautions and diluted with sterile normal salt solution until one sees 
only one trypanosome in every five or six microscopic fields using the 
high  dry  objective.  We  arbitrarily  designate  such  a  suspension  as 
+.  Varying  amounts  of  a  +  suspension  (1,  0.5,  0.25,  and  0.1  cc.) 
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taken of inoculating  several stock guinea pigs at the same time with 
different sized doses in order that the animals may not all die at ap- 
proximately  the  same  time  and  so make  the  recovery of  the  strain 
uncertain,  and  furthermore,  since  there  is  considerable  irregularity 
in finding parasites  in  the peripheral  blood of guinea pigs,  it is con- 
venient to have on hand  stock animals with varying grades of infec- 
tion so that there may be as little delay as possible when one wishes to 
infect series of animals for experimental purposes. 
Stock mice are inoculated intraperitoneally with a similar +  suspen- 
sion of infected blood in sterile normal salt solution.  The tail of the 
infected mouse, one showing a  +  +  +  or +  +  +  +  infection, is cleansed 
with alcohol and dried and is then bled directly into a small Petri dish 
containing  sterile  normal  saline  solution.  On account  of the  varia- 
tion in xTirulence of different species of trypanosomes, we use various 
sized  inoculating  doses  in  order  to  maintain  comparable  grades  of 
infections  With our particular  strains,  the doses used for mice are 
0.2 cc. of a  -4-  suspension of Tr. brucei, Tr. equiperdum, and Tr. evansi 
and 0.5 cc. of a  similar suspension of Tr. gambiense and Tr. equinum. 
Since it is not practicable to maintain stock strains of trypanosomes 
in all species of animals which may be used for therapeutic purposes, 
the proper  source of the  virus to be used in  the inoculation  of any 
given animal may be determined, in general, upon the basis of analogy 
of infection types; that is, the animals which show an acute, progres- 
sive, blood infection should be inoculated, if practicable, from a stock 
virus in which an infection of the same general type is maintained, and, 
conversely,  animals  showing  a  chronic,  cyclic  infection  should  be 
inoculated  from a  stock virus where a  like infection has been main- 
tained.  (The influence of passage upon the general type of infection 
produced,  as well as upon the virulence of the organism in question, 
will  be  discussed  at  greater  length  in  subsequent  sections  of  this 
paper.)  To meet these conditions, mice or rats to be used for therapeu- 
tic experiments should be inoculated with trypanosomes from a stock 
strain  carried in mice or rats,  while guinea pigs and rabbits may-be 
inoculated from a guinea pig stock.  The inoculation of such animals 
is carried out in the following way. 
In making  subinoculations  from  stock mice  to  series  of mice and 
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way as for stock inoculation and  the same sized inoculating dose is 
used.  If a large series of animals is required, it is convenient to anes- 
thetize the stock mouse and bleed directly from the heart into sterile 
salt solution.  When inoculating experimental series  of  guinea  pigs 
and rabbits,  it is our custom to bleed from the heart, using a  stock 
guinea pig which shows a  +  +  +  or  +  +  +  +  infection, and if a large 
number  of animals are  to  be  inoculated, it  is  a  wise precaution  to 
keep the blood suspension slightly warm.  We prefer guinea pigs  of 
350 to 500 gm. weight for therapeutic experiments and inoculate them 
intraperitoneally with 0.5  cc.  of  a  +  suspension  of  Tr.  brucei, Tr. 
equiperdum,  and Tr.  evansi  and with 1 cc.  of Tr. gambiense  and Tr. 
equinum.  Rabbits  are  infected intravenously with  1  cc. per kilo of 
body weight of a  similar +  suspension of Tr. brucei, Tr. equiperdum, 
and Tr.  evansi  and  1 cc.  per kilo of a  +  +  to  +  +  +  suspension of 
Tr.  gambiense and  Tr.  equinum.  We  have  found with  our  strains 
that intraperitoneal inoculations of mice, rats,  and guinea pigs,  and 
intravenous inoculations of rabbits give fairly uniform and as a  rule 
satisfactory results as  regards  the incubation period,  the grade  and 
course of the infection, and the length of life of the animal.  Certain 
variations in these points, regardless of the uniformity of dosage, are 
not infrequent in the larger animals as will appear later. 
Animals and Organisms. 
Since we have in mice and rats on the one hand, and in guinea pigs 
and rabbits on the other, two groups of animals in which experimental 
trypanosomiasis manifests itself as two essentially different types of 
infection, the chemotherapist is confronted by two distinct problems 
in the treatment of such infection types and hence a choice of animals 
offers an opportunity of testing the  therapeutic efficacy of  a  com- 
pound both as regards its trypanocidal action in the acute b]ood in- 
fections and its potency or  curative power in the chronic tissue in- 
fections.  In addition to this fundamental factor of the infection type, 
as exemplified by the animal species,  the question of time and expense 
must be  considered.  Mice and rats  are  the cheapest animals, they 
can  usually be  obtained in abundance,  are  easily handled,  and  the 
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paring  the  results  of treatment  of infections in mice and  rats  where 
the infection is of the same general  order,  we have found that  while 
there is little difference as regards ease of demonstration of therapeutic 
activity in the two animals,  mice are usually more easily cured than 
rats and the results of treatment are more constant and. mote uniform 
in character both as regards the absolute unit dose and the ratio of the 
curative to the tolerable dose.  Moreover, the end-result of treatment 
can be determined much more quickly in mice. 
Trypanosomal  infection  of  guinea  pigs  and  rabbits  is  a  chronic 
disease  in  which  tissue  involvement  and  not  blood  infection  is  the 
fundamental factor.  The treatment of such a pathological condition 
is a manifestly different problem than the treatment of an acute blood 
infection and is more nearly analogous to the naturally acquired forms 
of trypanosomiasis in man and animals.  However, the extensive use 
of  guinea  pigs  and  rabbits  entails  a  considerable  expenditure  of 
time and  money, and in our experiments  we have not attempted  to 
use them  for routine  preliminary  tests of trypanocidal  activity of a 
given substance but have reserved  them  for the more detailed study 
of those  substances which  have  shown  such  activity against  the  in- 
fection  in  mice  and  rats.  Other  animals,  such  as  monkeys,  dogs, 
horses, donkeys,.cattle, sheep, and  goats have been used by different 
workers especially to simulate naturally acquired forms of the disease. 
The infection in all of these animals  tends to be subacute or chronic 
with more or less tissue involvement, depending on the trypanosome 
used and  the size of the inoculating dose, thus falling into the group 
to which  the rabbit and  guinea pig belong, with a possible exception 
of the dog, which when infected with nagana,  for instance, may have 
an acute, rapidly fatal infection, with the almost constant presence of 
parasites in the peripheral blood. 
As in the selection of animals for chemotherapeutic study, a  choice 
of the  species of trypanosomes is of equal importance.  This  choice 
should  be  based  on  the  character  of  the  infection  produced  in  the 
various animals  employed and  the general  response  of the organism 
to therapeutic  agents as far as this is known.  In our work we have 
used .five species of pathogenic  trypanosomes  and  from  the point of 
view of the general character of infection produced, they fall into two 
groups.  Tr.  brucei and  Tr.  evansi  are highly virulent  for laboratory 118  EXPERIMENTAL  TRYPANOSOMIASIS 
animals, producing a relatively acute, rapidly progressive, and usually 
fatal infection, while organisms of the second group,  Tr. equiperdum, 
Tr.  gambiense, and  Tr.  equinum, are  less  virulent,  causing  a  more 
prolonged  course  of  infection  from  a  given  inoculating  dose  which 
terminates  fatally  in  mice  and  rabbits  and  usually  so  in  rats  and 
guinea  pigs.  It  must  be  borne  in  mind,  however, that  different 
strains of the same species of trypanosome may show wide divergences 
in  virulence  and  in  the  general  character  of the infection produced. 
This,  in part,  may be  due  to  the  length  of  time  of isolation of the 
particular  strain  from its original  source, together with the rate and 
number of.passages in the particular  species of stock animal,  as well 
as inherent  differences in virulence of individual  strains  of the same 
species.  The  factor of resistance  or  response of the  various  species 
of trypanosomes  to  therapeutic  agents  will be'considered  in  a  later 
section. 
The  general  character  of  the  infections ,  such  as  the  incubation 
period, course, and duration of the infection, as observed by a number 
of  investigators,  is  recorded in Tables I  to  VIII,  for  convenience  of 
comparison. 
A  complete  analysis of  the  data  contained  in  these tables is  im- 
possible  within  the  scope  of  this  paper,  but  on  the surface  it 
is evident  that  experimental  trypanosomiasis is an extremely varied 
condition  not  only as  to the  infections  produced  by different  spe- 
cies  of  trypanosomes' but  even  to  the  character  of  the  infections 
produced  by a  given  species  of  trypanosome  in  one  and  the same 
animal  species.  While  the  full  significance  of  these  facts  to  the 
chemotherapist can  hardly be gathered  from a  mere statistical  com- 
pilation,  it may  be  seen  that,  in  as  far  as  the  common  laboratory 
animals  are  concerned,  there is a  fairly well defined line of cleavage 
between  the  acute  infections  produced  by this  group  of organisms 
in  such  animals  as  mice  and  rats  on  the  one  hand,  and  the  more 
chronic infections in  guinea  pigs  and  rabbits  on  the  other.  As  we 
have  already  suggested,  these  differences  are  of  fundamental  im- 
portance,  but their  chemotherapeutic  significance  can be made  fully 
apparent  only by an elaboration of the clinical  characteristics  of the 
infections in  the  different  animal  species. v 
~t 
.-d 
,.6 
•  0  .it  O~ 
-u.t  ~o  o:mo~l  ~  ~ 
•  po!aad  ~,  t~ ~  00  ~¢~ 
uo!l~qn~uI  ~  eq  eq  /  ~ 
"u°!~l~°  ~  CJ 
-u!  ~o  a~no~[  ~  ~ 
"po!.lad  ~  '~  ~'~ 
uo!~qn~uI  ,~  eq  ~ 
-u! ~o olno~  ~  ,..4  o6 
•  po!~o~  ~.  .~ 
uo!l~qn~ul  ~  eq  eq 
-u!  jo a:motI  ~  ccJ 
uoD.eqnoui  .-~  ,~  c'q 
++ 
-u! jo o~no~I  ~  ~  ~  ,.4 
m 
119 
t~ 
P~ 
"~  09 
-o  = 
° 
gl 
~  ~.~ 
~  ~.~ 
~  .'~ 
~  .~  . 
~Ng "po!aad 
uo.~l'gqnau  I 
"uoD~Inao 
-u.t  ]o  olno}I 
e~ 
~5 
£ 
'[~At  A.Incd  ,4 
uotl~qnauI  ~  ~.  w~ 
[-u~  jo a~no~i 
•  i~^~ns  ~,  "~  ,"*  4  t,,. 
~o~  ~  ~  ~  ~4 
"pouad  ~, 
•  ~  uo!l~qn~u  I  ~ 
"uo!l~Inao  ~  ~.~ 
-u!  io  alno~  I  ~ 
uo.t~qn~u I  .~  ~  ~,,~ 
eq 
.~..~.~  ~  ~  F2 
•  ~  uotl~qnau I  ,.~ 
-u! fo o:mo~  ~  u5  ~  u5 
o 
•  ~  ~.~ 
120 eo 
•  po!a~  d 
uo!~qn~uI 
~ .~ ~  ": 
"uoD~in3o 
-u!  to a~no~I 
ox 
u°!~qnauI 
•  uo.~In~o  ~ 
-u!  ~o ~lno~I  ~ 
+-. 
toq~u~I  ~  oo  ? 
,4oo 
g 
"p~aad 
uo!~qnauI  .~  ~" 
•  uo!l~InaO  ~_) 
-u!  to alrto~I  ~. 
to q~ua'I  ~ 
uo~qnouI  .~ 
"uo!l~Inao  (.)  (.)  ~ 
•  I,~ ~ !.,~ns 
to q~u~ 
-po.uad 
uo!~qnau  I 
'uo!~inao 
o 
8 
121 
o 
o 
o  tj 
o 
o 
© 
o 
© 
4-+ 
.-I....- o 
.el 
"po!aml 
uo!;~qn~u  I 
"uo!1~In~o 
-u!  io  ~no~ 
°~ 
~.~ 
•  g  o 
~.~ 
o 
~.~ 
"1~^~^~  ~.  ~  ~  ~o 
-po.u~  g  ~  ~ 
'u~zln~o 
-u!  io ~no~i 
E & 
"po.uod 
uo!~qu~ui 
'uo!~ln~o 
-u! to ~uo~i 
•  po.u~d  ~. 
uoB~qu~uI  ~  ~e~ 
"uo!~inao 
-u! ~o  o~uolt 
o~ 
•  po.~d  ,~  ~ 
uoB'eqn:)uI 
'uo!~lnao  ~  ~  ~-~ 
;-u!  ~o  ~uo~I  ~  ~ 
e~  ~I  "~ 
122 
.c: 
°~ 
¢o 
c~ 
c~ 
[ 
0 
o 
..i.,._ o~ 
•  .~ ~d 
uoDsqnouI  ~ ~ ~* 
k 
e~ 
~A  °~ 
0 
©  -u!  to a:~no~I 
uo!~q~Ul  ~ 
-u! ~o o~no~  ~d 
"i'gA.iAan~  ~,  "~,o  '~  .~  ~  ~" 
~  ~  -~ 
"po!~ad 
uo!~qn~u  I 
"uoB~inao 
-u! Io a~no~I 
~o~.~  ~,  ~  ~  ~  ~ 
oO 
•  po!.md  ~  .~  ,~ 
~°D~qnauI  ~ 
"uo!l~inao  ~:~  ~-~ 
-u! jo o~no~[  ~ 
•  l~!A,n  s  ~  oo  ~ 
~o q~u~I  ~,  ,~  o~ 
•  po.u~a  ~,  ,o  ~  ~ 
uo!l~qn~uI  ~  ~ 
"uo!l~Inao  ~ 
-u! to a:mo~t  ~ 
~"  .:~  o 
123 
~J 
0 
0 
r.~ 
0 
"4-- 
0  °~ 
8 
0 ,-d 
~5 
,.-L 
q.q 
0 
•  po.taad  ~, 
uo.t:t~qn3u  I  ,~ 
"uo!~lnao 
-u! jo ~no'tI 
jo  q:t~uo"  I 
"po!aod 
uot~qn3u I 
"uo!~Irt3o 
-u.l  JO olno~t 
"I~ZqAans  ~  ~  ~ 
uot~t~qn3uI  z¢ 
"uo!z~ln~o 
-u~  jo o:luo~I 
•  [~Ar,,.ans  R  ~  ~  oc 
uo!:leqn3u  I  ,~ 
"uo!:t~In3o 
-u! ~o ~'tuo  H 
uo!~qnau I  .~ 
•  uOD~in3o  .  ~ 
-u.t  ~o a~uo~I  ~  t~ 
°~  ~. 
124 
~3 °  ~=~ 
d 
o 
-po!aad 
uo!~qn~u  I 
"uo!~*lnao 
-u! ~o a~no  H 
"I~AIAJnS  ~  ~  e=~ 
•  ~,.C~  ,,5 
"uo!~InOO  L~  ~-~ 
-u! jo o~uo~I  ~  ~ 
"po!a~d 
uo~:~qnau  I 
"uo!~Inao 
-u.t ~o o:lno  H 
•  ~.~  ~ ~  .~  o  -,- 
~o~  ~  ~  ~  ~o.,-~, 
c~ 
"po!a~l  R 
uo!~qn~uI  .~ 
"uo!~In~o 
-u! ~o o~no  H 
• ~^.~  ~  ~  ,~ 
~o  ~u~  ~  ~  ~  ~ 
N  "po!aod  ~ 
uo!:l~qn~uI  ~  eq 
"uoD~In~o 
-u! ~o o~uo~ 
125 
c~ 
I 
oO 
G 
o 
0 
c~ 
t> "~  .4- 
•  pov~I  ~  ~  f 
•  uo!~inao  L~ 
-m.  }o a~no~i 
jo q~gua-  I 
O~  "po!a~d 
uo!1~qnauI 
"uo!~slnao 
-u! }o a~no~I 
]o q~uo"  I  *~  ~  c~ 
"r, 
.~  'po!aad  ~  o0 
u°!~qn~ul  .g 
"uo!1~lnao 
-u! }o o~no~I 
¢oa 
"~.~  ~  ~" 
jo  q~ua"  I  .~  ~  c~ 
"po!aod 
uo!~qnauI 
"uo!~lnao 
-u! ~o ~no~I 
41-  ,,-.,  "I~AI.Aans 
"o6 
uo!~qnauI  -~  [ 
"uo!~c'ir~o 
-u! ]o a~no~I 
m 
126 
c2 
Z 
¢,o¢ 
o 
++ 
v; 
,¢..- 
,< LOUISE  PEARCE  AND  WADE  It.  BROWN  127 
Acute Blood Infections of Mice and Rats. 
The  experimental  infection  of  pathogenic  trypanosomes  in  mice 
and rats is, generally speaking, an acute, progressive, and fatal disease 
characterized by the constant presence of parasites in the peripheral 
blood.  With most strains,  the parasites  multiply continuously and 
quite regularly from the time they first appear in the circulation until 
death, when they seem to be more numerous than the red corpuscles. 
Signs or symptoms of the infection in these animals are rarely seen up 
to within a  few hours of death.  The incubation period, the interval 
of time between the inoculation and the first appearance of trypano- 
somes in the peripheral blood, varies in any instance with the species 
of  organism,  the  size  of  the  inoculating  dose,  the  potency of  the 
virus,  and  the route  of inoculation.  With  the intraperitoneal and 
intravenous  routes  the  incubation  period  is  shorter  than  with  the 
subcutaneous and, generally speaking,  the more virulent the species 
of trypanosome, the shorter is the incubation period.  We have used 
our strain of Tr.  brucei  for all routine work and a  description of this 
infection wili serve as a type of the acute blood infections of mice and 
rats. 
Within 24 hours after hatraperitoneal inoculation in mice of a small 
dose of infected blood (0.2  cc. of a  +  suspension), parasites are found 
in the circulating blood (+  grade).  From the time of their appear- 
ance, their number constantly and regularly increases and in 48 hours, 
the infection is  usually of a  +  +  +  grade.  On  the 3rd day (60 to 
72  hours), it is  +  +  +  +  and the parasites  approach the number of 
the  red  blood  corpuscles.  With  an  infection of  the  virulence and 
severity of our strain of nagana, mice will die at the end of the 3rd 
or the beginning of the 4th day.  The animals appear perfectly healthy 
up to the time of death.  This may be ushered in by a short period of 
excitement with tremors, jerking of the limbs, and convulsions, which 
may be of extreme degree; or the mice may appear drowsy just prior 
to death and die without  convulsions.  Rats  also, in  our  experience, 
may have  convulsive  attacks  before death or  may become  drowsy 
during the last hours of life and die without other signs. 
The infection produced by Tr.  brucei  in rats is quite similar to that 
in mice, with the exceptio  n  that rats live longer than mice after the 128  EXPERIMENTAL  TRYPANOSOMIASLq 
number of parasites in the blood has reached a  +  +  +  +  grade.  The 
incubation  period  after  intra~eritoneal  inoculation is slightly longer. 
The rapidity of development of the infection is quite comparable with 
that observed in mice and a  +  +  +  +  grade is reached within 3 to 4 
days.  With  such an infection,  rats will live from  1 to  2. days,  thus 
dying 4  to 6  days after inoculation. 
The infection produced in mice and  rats by other species of patho- 
genic trypanosomes which we have used is  comparable with  that  of 
Tr.  brucei as  regards  the  general  type of  blood  infection,  although 
there  are  certain  minor variations  which  should be considered.  In- 
fections with Tr. equiperdum and  Tr. evansi are somewhat less acute 
than with Tr. brucei, mice living from 4 to 8 days and rats from 7 to 
8  days.  Occasionally the  progressive course of a  dourine  (Tr. equi- 
perdum)  infection will be interrupted  by a  day or  two in which  de- 
creasing  numbers  of  parasites  are  found  in  the  circulating  blood. 
The incubation period for both Tr. equiperdum and Tr. evansi in mice 
is from 24 to 36 hours and in rats is usually slightly longer  (approxi- 
mately 36 hours), after  intraperitoneal  inoculation.  Infections pro- 
duced with our strains of Tr. gambiense are more chronic in characterl 
mice dying in 5 to 8 days and  rats in 5 to  11  days.  It is uniformly 
fatal for both species of animals.  The incubation period for mice is 
24 to 48 hours and for rats usually 48 to 72 hours after intraperitoneal 
inoculation.  With  our strain  of Tr.  equinum  also,  a  slower type of 
infection is produced, mice and rats usually dying in 5 to 8 days with 
an incubation  period  of  24  to 48  hours.  Occasionally the  infection 
may  run  a  curious  relapsing  course.  On  the  4th  or  5th  day,  the 
parasites  in the peripheral  blood will greatly diminish  in number for 
2 to 4 days.  At the end of this time, they will recur with increasing 
rapidity and death will follow in 10 to 14 days after inoculation.  We 
have  noted  this  relapsing  type of caderas  infection more  frequently 
in mice than in rats, but, on the other hand, we have seen many more 
caderas mice than rats.  Occasionally also, we have seen spontaneous 
recovery  in  rats  infected  comparatively  lightly  with  Tr.  equinum, 
but  this  is not  the  rule  with  our strain  of  this  organism.  Laveran 
and  Mesnil  draw  attention  to  signs  and  symptoms  of  approaching 
death in surra, caderas, and dourine mice which are not usually shown 
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a rough  and  bristling  coat.  The  animals  are insensitive  to external 
stimuli, the eyes are usually closed, and the corneas may become white 
and opaque just prior to death. 
Chronic Tissue Infections  of Guinea Pigs and Rabbits. 
Experimental  trypanosomiasis  of rabbits,  and  to  a  certain  extent 
of  guinea  pigs  also,  constitutes  a  type  of infection in  which  tissue 
involvement  is  a  conspicuous  and  predominating  feature,  and  in 
this  respect contrasts  sharply with  the  blood infection  of  mice  and 
rats.  In neither  guinea pigs nor rabbits is the presence of parasites 
in the peripheral  blood a  constant characteristic  of the infection and 
in rabbits, in our opinion,  it is of distinctly minor importance.  The 
visible  or  external  signs  of  tissue  involvement  of  guinea  pigs,  it  is 
true, may not be so striking  or so constant as they are in the rabbit 
except in  certain  chronic  infections  of long duration.  On  the other 
hand,  the infection is not of the acute type seen in mice and rats in 
which  the  parasitic  invasion  of  the  peripheral  blood  stream  is  the 
characteristic and constant feature.  Consequently, guinea pigs would 
seem to be more appropriately  classed with rabbits in  the  group  of 
chronic or subacute tissue infections. 
Trypanosomiasis  in  Guinea  Pigs.--Guinea  pigs  inoculated  intra- 
peritoneally with our strain  of Tr. brucei (0.5  cc. of a  +  suspension) 
will show a  few parasites in the circulating blood within 3 to 7 days. 
The number of trypanosomes increases slowly for a few days reaching 
a  +  +  to  +  +  +  grade in about a  week after their first appearance, 
when  quite  suddenly  they disappear  from  the peripheral  blood and 
one  may  examine  a  large  number  of  films  without  finding  a  single 
trypanosome.  This  condition  continues  for  an  irregular  period  of 
time,  usually  1 to  3  weeks during  which,  although  one may find an 
occasional  organism  in  blood  films,  the  examinations  are  usually 
negative.  The  parasites  invade  the  peripheral  blood  stream  again 
as suddenly as they left it and with this  second appearance  increase 
rapidly and fairly uniformly in number reaching a +  +  +  to a +  +  +  + 
grade of infection in about a week.  Death usually occurs at this time 
and is comparatively sudden.  It is generally ushered in by local and 
general muscular tremors, twitching of the limbs, respiratory distress, 130  EXPERIMENTAL  TRYPANOSOMIASIS 
general  convulsions,  and  stupor with  some spasticity  lasting  from  ½ 
to  several hours.  The  average  length  of life of guinea pigs infected 
with our strain of Tr. brucei is 4 weeks, although many have died in 2 
to 3 weeks and others have lived 2 months.  With a smaller inoculat- 
ing dose than we usually use and  a  consequently less acute and more 
prolonged  grade  of infection,  we have had  some nagana  guinea  pigs 
which  have  shown  clinical  signs  of  the  disease.  In  these  animals, 
there has been slight  loss of hair  especially about the eyes and  over 
the back, more or less edema of the  external  genitalia  and  anus, to- 
gether with loss of  weight or even emaciation.  Such a chronic  type 
of nagana infection, however, is unusual with our strain of  Tr. brucei, 
which is quite virulent for guinea pigs.  Guinea pigs receiving massive 
inoculating  doses of Tr. brucei usually die within  a  week's time and 
do  not  show the  characteristic  cyclic appearance  of parasites  in the 
circulating  blood.  Such  an  overwhelming  infection  is  comparable 
with  the  acute  type seen in  mice and  rats,  although  in  the  case  of 
guinea  pigs,  the  uniformly  progressive  increase  of  trypanosomes in 
the blood may not occur. 
Infections  in  guinea  pigs  with  our  strains  of  Tr.  equiperdum  and 
Tr.  evansi  are  similar  in  general  to  Tr.  brucei  infections,  although 
with both of these organisms, the course of the disease is of somewhat 
longer duration.  The characteristic  cyclic invasion of the peripheral 
blood  stream  by  trypanosomes  is  seen  in  infections  with  both  Tr. 
equiperdum and  Tr. evansi,  but  with  Tr. equiperdum especially there 
may be more than one period of remission in which no organisms are 
found  in  the  blood.  With  our  nagana  strain,  guinea  pigs  usually 
die  at  the  height  of  the  second  cycle,  or invasion  of the  peripheral 
blood, but in  Tr. equiperdum infections,  there is  a  tendency toward 
more than  two cycles.  The succeeding cycles in which one may find 
parasites  are  usually  shorter  than  the  earlier  ones.  The  length  of 
life of guinea pigs infected with Tr. equiperdum is quite irregular  but 
averages from 5  to  7 weeks.  Guinea pigs  infected  with  Tr.  evansi 
live on an average of 4 to 7 weeks but here again, there is considerable 
irregularity  and  definite statements  are difficult to make.  We have 
had  no  spontaneous  recoveries  with  either  strain  in  this  species  of 
animal.  Chronic infections with Tr. equiperdum  and with Tr.  evansi 
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such as the loss of hair, chronic lesions of the skin, and edema of the 
genitalia  are  not  infrequently seen,  an  extreme grade  of  which  is 
shown by the dourine guinea pig in Figs.  1 and 2.  This guinea pig 
lived 106 days and showed conspicuous signs of the disease, consisting 
of extensive loss of hair with scaling and thickening of the skin, marked 
edema of the eyelids, external genitalia, and anus, and a profuse muco- 
purulent nasal discharge.  The animal was extremely weak, thin, and 
emaciated, with muscular tremors, and blood films showed large num- 
bers of trypanosomes. 
Infections  in  guinea  pigs  with  our  strain  of  Tr.  gambiense are 
extremely irregular both as regards the cyclic character of the infection 
and the length of life of the animal.  As a  rule, the condition is out- 
spokenly chronic, guinea  pigs  surviving  from  2  to  6  months  and 
sometimes as long as 1 year.  The periods of remission in which no 
parasites  are found in the peripheral  blood  are usually considerably 
longer  than  those  of  guinea  pigs  infected  with  other  pathogenic 
trypanosomes.  The  number  of  cycles  is  very  irregular  and  even 
average estimates are difficult to make.  Clinical signs and symptoms 
may be present in infected animals of long survival, but they are not 
so prominent or so conspicuous in our experience as in the chronic in- 
fections  of  other  trypanosomes.  Spontaneous  recovery  of  lightly 
infected guinea pigs is not uncommon.  One such guinea pig in our 
possession has lived over 4  years and shows no signs of the disease. 
w  . 
Infection of guinea pigs with our strain of Tr.  equinum is  also  a 
chronic condition, similar to thdt of Tr. gambiense, although the aver- 
age time of survival is somewhat shorter.  Guinea pigs usually live 
from 1 to 2 months, although survivals of 3, 4, and 5 months are not 
at all uncommon.  We have had no instance of spontaneous recovery 
of guinea pigs with our caderas strain.  External tissue involvement 
is confined, in our experience, to edematous swelling of the scrotum 
and sheath.  The cyclic invasion of the peripheral blood by trypano- 
somes is a  characteristic feature, but as with Tr. gambiense, the infec- 
tion is extremely irregular. 
Experimental  trypanosomiasis  of guinea pigs,  therefore, presents 
certain features which contrast sharply with the infection of mice and 
rats.  There is a characteristic cyclic invasion of the peripheral blood 
by  trypanosomes and  in  the periods  of remission,  no  parasites  are 132  EXPERIMENTAL  TRYPANOSOMIASIS 
found.  Although the number of trypanosomes increases in the blood 
during these cycles of blood invasion,  this increase is by no means  so 
regular or so uniformly progressive as is usually the rule in the blood 
infections  of mice and  rats.  While  the length  of survival  of guinea 
pigs is extremely irregular,  generally speaking it is a  matter of weeks 
and  months  with  the  ultimate  possibility  of  spontaneous  recovery. 
In addition, in the more chronic infections, clinical signs may appear, 
all of which is in  striking  contrast  to  the  infection in mice and  rats 
with the same organisms.  These features of the infection in guinea 
pigs are indicative of two conditions of chemotherapeutic significance: 
first,  the  interposing  of  animal  resistance  to  the  progress  of  the 
infection, and second, the establishment of true tissue lesions, neither 
of which,  with rare  exceptions, is in evidence in either  the mouse or 
rat infection.  One of these factors, that of animal resistance, reaches 
its highest point in the guinea pig; the other, that of tissue involvement 
and reaction, is most typically developed in the rabbit. 
Trypanosomiasis in the Rabbit.--Trypanosomiasis  in  the  rabbit  as 
in the guinea pig  is an infection of  considerable duration  but char- 
acterized  chiefly by the  clinical  signs  and  manifestations  of disease, 
while  the  finding  of  trypanosomes  in  the  circulating  brood  plays  a 
distinctly  minor  part.  Thus,  in  an  advanced  condition  of  rabbit 
trypanosomiasis  with  pronounced  clinical  signs  and  symp'toms,  no 
trypanosomes or,  at best, only a  few may be found in blood films to 
indicate the existence of an infection.  In the majority of the experi- 
ments, we have used a strain of Tr. brucei carried constantly in stock 
guinea pigs and  the rabbits were inoculated intravenously with  1 cc. 
of a  +  blood suspension per kilo of body weight.  In these infections 
the initial signs of the disease usually appeared in from 5 to 7 days and 
the length of survival of the untreated animals was from 1 to 3 months. 
More animals  died within  the first 5 weeks, however,  than  survived 
I 
for a  longer period.  The infection is uniformly fatal in rabbits. 
The  earliest signs of nagana  infection in rabbits appear about the 
head  and  external  genitalia.  Slight  puffiness  of  the  upper  eyelids, 
swelling of the lips, reddening and slight thickening of the base of the 
ears,  together  with  a  similar  appearance  of  the  external  genitalia, 
may  all  occur within  1  week  after  inoculation.  Usually,  however, 
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few days, new areas are affected.  The swelling of one or both upper 
eyelids with injection of the conjunctival vessels is a  common initial 
sign and may be the only one for several days (Figs. 3 and 4).  This 
condition increases rapidly and the lower lids may also become involved 
although  usually less severely.  In  a  few days,  the  eyes are not  in- 
frequently completely closed (Figs. 5 and 6).  By this time, the margins 
of the lids are considerably reddened, the eyelashes are falling out, and 
there  is a  thick yellow exudate gluing  the lids  together. 
Involvement of the base of one or both ears is likewise a characteris- 
tic early sign and is easily detected by holding the ear up against the 
light.  Extending  upward  from  the  base  of  the  ear,  one  can  see  a 
faint  reddening  of  the  tissues  with  dilatation  and congestion of the 
blood vessels.  A  day or two later,  the base of the  ear  is distinctly 
thickened  and  feels  warm  to  the  touch.  The  swelling  rapidly  in- 
creases both in extent and degree until the ear begins to droop (Figs. 
7 and 8), and in a few days it is so swollen and heavy that the animal 
can no longer hold it erect (Figs. 9 and 10).  The hair over the swollen 
area  soon falls out and  the  skin becomes brawny, rough,  and  scaly. 
Crusts and scabs form and not infrequently actual ulceration of tissue 
occurs (Figs.  11,  13, and 14). 
About  the  time  that  the  eyes  are  partially  closed  and  the  ears 
beginning to droop, subcutaneous swelling of the face and upper lips 
appears  (Figs.  11  and  12).  In some rabbits,  however,  swelling  of 
one upper lip was the first sign of the disease.  At first,  these swell- 
ings  are  rather  puffy and  edematous,  but  they  soon  become  hard, 
indurated,  and markedly reddened.  In the beginning,  they are small 
and focal, the entire lip itself not necessarily being involved but they 
rapidly increase in size, affecting the entire lip and not uncommonly 
both lips.  A  similar  development may occur in  the facial  swellings 
which may become so marked  that  the contour from the base of the 
ear  to the nose and  lips is an  extreme convex curve.  The  swellings 
of the face and lips, however, may remain more localized and when the 
early  edema has  disappeared,  the  deeper tissues are  seen  to  be still 
involved.  This is noticeably the case over the bridge of the nose in 
which  swelling  and  induration  of  the  periosteum with  subsequent 
ulceration  is not uncommon.  There have  also been a  few instances 
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to  secondary infection.  Accompanying the  facial  and  lip  involve. 
ment,  there is a  nasal discharge which usually begins in the 2nd or 
3rd week of the infection.  This discharge is at first mucoid in char- 
acter and usually slight in amount but as the disease progresses, it 
may become very profuse with the formation of thick yellow crusts 
about the nostrils (Fig. 23). 
Involvement  of  the  external  genitalia  practically  always  occurs 
either as an early or late sign of the disease.  In the majority of our 
rabbits, it occurred early and not infrequently was the first sign noted. 
In male rabbits, slight swelling and reddening of the prepuce or slight 
enlargement of one or both  testicles are  the initial  signs  (Fig.  15). 
The testicle feels hot, edematous, and somewhat elastic.  In a  day or 
two,  it may become enlarged to  two  or three times its  normal size 
(Fig.  16).  The  scrotum is  extremely tense  and  glistening and  the 
testicle itself becomes markedly resistant and hard.  As the involve- 
ment advances, the actual swelling usually decreases somewhat but 
the  testicle  becomes more  indurated  and  rubbery  with  a  brawny, 
thfckened scrotum (Figs. 17 and 18), which may finally lead to super- 
ficial excoriation or even ulceration (Fig.  17).  The condition of the 
prepuce is similar to that of the scrotum and testicles.  At first, there 
is  considerable swelling, congestion, and induration (Fig.  19) while in 
advanced grades of infection, widespread ulceration may occur (Fig. 
20).  Occasionally, the penis becomes swollen and indurated with but 
little involvement of the prepuce (Fig. 21), or the prepucial condition 
may practically clear up  to  be followed by the enlargement of  the 
penis.  In female rabbits,  the external genitalia are similarly affected 
(Fig.  22).  The  labia  are markedly swollen  and  congested and  the 
vaginal  mucous  membrane becomes involved  in  the  same process. 
The  anus  practically  always  shows  some  swelling  and  induration, 
although usually this is not a particularly early sign of the infection, 
but follows the swelling of the external genitalia.  Diarrhea is not an 
uncommon  symptom  and  occasionally  a  white  mucous  discharge 
from the rectum occurs, suggesting the involvement of the intestinal 
mucosa in the infectious process. 
A certain proportion of rabbits showing some or all of the signs of 
nagana infection described above usually die from 3 to 6 weeks after 
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weakened and eat but little (Fig. 25).  The picture of such advanced 
infections is very characteristic  (Figs.  18,  23,  and 24).  When,  how- 
ever,  the  development of the infectious process is less rapid,  with  a 
consequently longer survival of the animal, a  more chronic patholog- 
ical condition occurs.  These rabbits survive 2 to 3 months and show 
an exaggeration of the local signs and symptoms of the advanced and 
less chronic disease.  The most striking  signs in such animals are the 
loss of hair over large areas of skin and necrosis of both soft and bony 
tissues  (Figs.  26,  27,  and  28).  Most of the face,  for instance,  as in 
Fig. 26, may be entirely denuded of hair.  The skin is scaly, is greatly 
thickened,  and has lost its elasticity.  It is difficult to pick up.  The 
testicles and  prepuce may become extremely indurated  and  on pal- 
pation,  one  gets  the  impression  of  fibrosis  of  the  testicular  tissue. 
In the rabbit shown in Fig. 27, there is a conspicuous deep ulceration 
over the bridge of the nose.  Not only have the soft parts in this area 
been completely destroyed but the cartilage  and bone are beginning 
to show necrosis.  In this particular animal, there was little secondary 
infection of the ulcerated area but this may occur to a marked degree 
as shown in Fig. 28.  This rabbit was an extreme example of a chronic 
trypanosomal  infection.  There  was  an  extensive  ulceration  of  the 
soft tissue of the entire face, nose, and lips with the formation of thick 
adherent  crusts.  The  mucopurulent  discharge  from  the  nose  was 
especially  profuse  and  foul  smelling.  In  addition  to  the  striking 
condition of the face, there was also marked involvement of both ears, 
both upper eyelids, and external genitalia together with great weakness 
and emaciation.  Loss of hair in areas other than the face is a common 
sign  in  chronic  infections.  It  is perhaps  most frequent  on  the  legs 
and  may extend down to the feet and  toes  (Figs.  29 and 30).  The 
denuded  skin becomes considerably  thickened  and  scaly and  super- 
ficial ulceration may occur with a slight sticky yellow exudate as well 
as  some bleeding  and  the  subsequent  formation  of crusts.  In a few 
instances, we have seen a patchy loss of hair on the backs of rabbits. 
Rabbits infected  with  other  strains  of  trypanosomes  have  shown 
much  the  same  clinical  picture  as  tl~ose  infected  with  Tr.  brucei. 
Rabbits infected with comparable doses of our strain of Tr. gambiense 
(1 cc. of a  +  +  or +  +  +  suspension per kilo of body weight) survived 
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to  15  days after inoculation.  With  this  strain  of Tr. gambiense, we 
have been struck with the great frequency and comparative severity 
of genital  involvement.  In  one  series  of nineteen  rabbits,  this  was 
the  first  sign  noted  in  twelve  and  it  persisted  in  all  of  them  with 
relatively  slight  involvement  of  the  face  and  head.  However,  it 
should  be  stated  that  our nagana  rabbits  greatly  outnumber  those 
infected with  Tr.  gambiense and  the  above observation may now be 
true for a  larger series. 
Rabbit  infection  produced  by our  strain  of  Tr.  equinum  is  quite 
comparable with Tr. brucei as regards length of survival and  clinical 
signs,  but in this  connection it should be noted that  the inoculating 
doses of Tr.  equinum  are purposely larger  than  those of Tr.  brucei. 
Our  experiments  with  infections  produced  by  Tr.  equiperdum  and 
Tr.  evansi  in  rabbits  are  not  extensive enough  to justify  any  effort 
to  analyze  these infections  in  detail.  As  far  as  our  experience  has 
gone,  the clinical  course of the disease caused by these organisms in 
rabbits is similar to that of nagana. 
These descriptions of trypanosomiasis in laboratory animals are, of 
course, but type descriptions of the infection as it usually occurs and 
it  should  be appreciated  that  the  experimental  disease is  subject to 
very marked  alteration  in part  due  to  "natural"  or inherent  causes 
but in part also due to causes subject to the control of the investigator. 
Some Factors Influencing the Course of the Infection. 
In  addition  to  the  animal  species as  a  determining  factor in  the 
type of trypanosomal infection, there are certain other factors which 
may influence the character and termination of the infection of a given 
organism  in any particular  animal  species.  First,  the dose of infect- 
ing  organisms,  other  things  being  equal,  may be so regulated  as  to 
insure within reasonable limits  the general  character of the infection 
together  with  the  desired  length  of  life  of  the  inoculated  animal. 
This is comparatively easily obtained in mouse and rat infections with 
the more virulent  organisms ~tnd may be quite closely approximated 
with  the less virulent  species.  With larger  animals,  in which  as we 
have emphasized, a different type of infection obtains, such exactness 
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dose, one may produce a relatively rapid and acute infection or a more 
prolonged diseased condition or with the less virulent organisms,  espe- 
cially, a mild grade of infection which may end in spontaneous recovery. 
To meet the requirements of  a more  exact dosage,  Kolmer  (22)  has 
devised a method of counting the trypanosomes in order to inoculate 
animals  with known  numbers  of organisms:  The  mode or route of 
inoculation  merely  affects  the  period  of incubation,  the  parasites 
appearing in the blood or the signs of the infection developing sooner 
after intraperitoneal  or intravenous  than after subcutaneous inocula- 
tion. 
Secondly,  the virulence  of different  species of trypanosomes must 
be taken  into  account.  Generally  speaking,  Tr.  brucei is  naturally 
the most virulent  species for the more common laboratory animals. 
Tr. dimorphon,  Tr. congolense, Tr. equiperdum,  and Tr.  equinum  are 
among the less virulent and between these extremes in varying degree 
are  Tr. evansi,  Tr. gambiense,  and  Tr. rhodesiense.  In  addition,  the 
virulence  of various strains  of the  same species must be considered. 
Although a freshly isolated strain is usually less virulent for laboratory 
animals than one that has been carried in stock animals for some time, 
this  may not  always be  the  case.  A  freshly  isolated  strain  of  Tr. 
gambiense, for instance, may be highly virulent for a large number of 
animals, while another freshly isolated strain may produce a chronic or 
subacute  experimental  infection  in  laboratory  animals  which  may 
or may not end in spontaneous recovery.  Moreover, different strains 
of the same species may show considerable variation in virulence  for 
a  given animal  species.  With certain  strains  of Tr. equiperdum,  for 
instance,  mice and rats are easily infected, while with others,  the in- 
fecting power for these animals is absent or of a very low grade:  Most 
strains of Tr. brucei are highly virulent for mice, killing them in 3 to 
4  days,  yet  the  Ouganda  strain  of Bruce  (23),  kept in  stock mice, 
killed regularly in  10 to 12 days. 
The  factor  of  acquired  virulence  of a  particular  strain  must  be 
kept  in  mind  as  well  as  its  "natural"  or  inherent  virulence.  The 
virulence of any strain is subject to experimental influences as by its 
"direct" passage in the same animal species or by "crossed" passage 
in  different  species as well as  by its  rate  of passage.  Thomas  and 
Breinl  (17),  speaking of Tr. gambiense, state that  "if a  strain  be re- 138  EXPERIMENTAL  TRYPANOSOMIASIS 
peatedly and quickly run through animals of the same species, it will 
acquire a  certain virulency for such a  species, but this continues only 
so long  as  the  strain  is  not  run  through  other  species of animals." 
However, according to Laveran  (24), who gives the following r~sum~ 
of his experiments, this augmentation of virulence by continued direct 
passage  is  not  characteristic  for  all  species  of  trypanosomes:  "For 
Tr. evansi  (surra  of Mauritius  and  of Mbori)  and for Tr. gambiense, 
virulence  is  increased  following a  series  of passages  in  guinea  pigs. 
For  Tr.  of Togoland  (nagana),  the  virulence  is  diminished  and  for 
Tr. congolense, the virulence is not varied in spite of the great number 
of passages."  It  should be noted,  however,  that  these experiments 
dealt with the guinea pig, an animal which in our experience may give 
the  most varied  results depending  upon  the  uncertain  factor  of the 
infection cycle.  According to other authors,  the virulence of a strain 
by continued direct passage in the same animal species may be modi- 
fied by this  procedure for other  animals  as  well.  The  modification 
may  take  the  form  of an  increased  or  of  an  attenuated  virulence. 
Martini  (25)  reports  experiments  with  a  nagana  strain  (Togoland) 
which after passage in mice and rats was increased in virulence not only 
for mice  and  rats  but for dogs, while on  the other hand,  the viruses 
of passage through Equida~, rabbits, and guinea pigs were very slightly 
virulent for rats, mice, and dogs.  Laveran and Mesnil  (26)  cite the 
case also of a strain of Tr. equiperdum which at first killed mice regularly 
in 5 to  10 days.  This strain  was then kept in stock guinea pigs for 
2 to 3 months and at the end of this  time transferred back to mice. 
But it had  become so much less virulent  for mice that  the animals 
had only the slightest grade of infection which ended in spontaneous 
recovety  and  the  strain  was  lost.  As  a  general  rule,  however,  it 
seems to be the consensus of opinion that for most strains of trypano- 
somes, continued direct passage in any one species of animal increases 
the virulence  for  that  particular  animal  species  and  tlmt  crossed 
passage,  from  one  animal  species to  another,  usually decreases  the 
virulence.  Further,  the  examples  of  altered  virulence  in  trypano- 
some  strains  cited  above are  striking  illustrations  of  the  influence 
of animal species, as measured by  the  infection  type,  upon  the  or- 
ganism  in  question.  In  addition,  the  rate  of  passage  of  a  given 
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fer from animal  to animal  at the height  of the infection  tends to in- 
crease the virulence of the strain. 
The viability or infecting power of the virus is still another  factor 
which  measurably  influences  the  character  and  termination  of  any 
particular infection in a given animal.  The blood used for inoculation 
should  be  taken  from  a  live  or  freshly  killed  stock  animal,  since 
pathogenic  trypanosomes  soon  lose  their  infective  power  after  the 
death of the host as has been shown by a number of observers.  The 
stage of the infection of the stock animal  should also be considered. 
In the continually progressive infection of mice and rats, the number 
of parasites in the blood constantly increases, but immediately before 
or at the time of death of the animal,  a number of the parasites show 
degenerative  changes  and  loss  of  motility.  After  diluting  the 
blood for inoculation,  it is apparent  that  under  these conditions in- 
oculating doses, which contain comparatively few parasites, would be 
extremely  irregular  as  regards  their  infective  power.  Moreover, 
toward  the  terminal  stages of an infection,  there are present  in  the 
blood certain "immune substances," the nature and amount of which 
are as yet little understood.  If in an endeavor to compensate for the 
comparatively  few  infecting  organisms  in  the  inoculating  dose, 
one  increases  either  the  size  or  the  concentration  of  the  dose, the 
amount  of immune  substances is also increased  at the same time, so 
that in any case the infecting power of such blood in proportion to the 
number  of  trypanosomes  may be considerably diminished.  On  the 
other hand,  if the blood is taken  at  an  early stage of the infection, 
when there'are  comparatively few parasites,  it is difficult to make an 
even  suspension  and  an  irregularity  in  the  infection  produced  will 
result.  If subinoculations are to be made from guinea pigs, the cyclic 
type of infection, characteristic of this animal species, should be borne 
in mind.  When the infection is at its height, just prior to a blood crisis 
in which the parasites disappear from the circulating blood, degenera- 
tive  forms  and  agglomerations  of  the organisms  are frequent.  Ob- 
viously, this stage as well as the periods of remissions are not favor- 
able times for subinoculations into series of animals in which regularity 
of incubation  together with uniformity of character and  termination 
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Resistance of Specifi.c Organisms.to  Therapeutic  Agents. 
Another set of conditions which the chemotherapist must consider 
is introduced by the factors of specific and strain resistance of trypano- 
somes to therapeutic  agents as far as these facts are known.  There 
have been numerous  examples of such resistance  of different species 
to  a  particular  therapeutic  agent  reported  in  the  literature.  In his 
first  experiments  on  the  therapy  of  experimental  trypanosomiasis, 
Ehrlich noted that trypan red was less active in nagana than in caderas 
mice.  Atoxyl, which has a marked action on Tr. gambiense infections 
according  to  Mesnil,  Nicolle,  and  Aubert,  acts  only  feebly on  Tr. 
dimorphon  (Wenyon,  Laveran)  and  has  no  action  whatever  on  Tr. 
congolense  (Laveran)  (27).  Monfort  (28), in  treating  infected mice 
with  arsenophenylglycine,  found  from  the  point  of view of relapses 
that  Tr. gambiense infections  were the most easily cured,  Tr. rhode- 
siense  followed, Tr.  dimorphon  were only fairly easy,  while  Tr.  con- 
golense  infections  were  highly  refractory  to  the  drug,  sterilization 
being only of short duration.  Laveran  (29),  who studied the  treat- 
ment  of Tr.  dimorphon  and  Tr.  congolense infections in guinea  pigs 
with arsenic trisulfide, noted that this compound which had but little 
action against the first infection was very efficacious against the second. 
Mesnil and Brimont (30) state that surra and dourine infections were 
less resistant  to  tartar  emetic  than  were nagana,  caderas,  Tr.  gam- 
biense, and Tr. dimorphon infections.  D anysz (31) found that Tr. rhode- 
siense  infection  in  mice  was more  resistant  to  885  than  Tr.  evansi, 
and in order to obtain the same curative result, it was necessary to use 
twice as large a dose.  More recently, Yakimoff and Wassilevsky (12) 
found, in working with dourine infections in mice,  that  the  ratio  of 
the  curative  to  the  tolerable  dose of  1021 (luargol)  was  1:3,  while 
Danysz reported the striking  ratios of  1:80 in surra mice and  1:100 
in mice infected with Tr. gambiense.  In general, with our five strains, 
we have found  that  Tr.  equinum is  the  least  resistant  and  that  Tr. 
gambiense,  Tr.  brucei, Tr.  evansi, and  Tr.  equiperdum  follow in  the 
order named. 
The  differentiation  between  the  virulence  and  the  resistance  of 
species of trypanosomes should be borne in mind since a marked re- 
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high  degree  of  virulence  and  vice versa.  The  classical  example  of 
Tr. lewisi may be  cited as  an  organism of extremely low virulence 
but of high resistance to all known therapeutic agents.  Furthermore, 
it should be emphasized that the resistance of the various strains of a 
species of trypanosome is not constant and that the widest differences 
in the resistance of different strains may be encountered. 
Finally, as Laveran and Mesnil and Ehrlich have pointed out, one 
cannot  conclude  fromthe  therapeutic  results  obtained  against  a 
particular infection in one species of animals what the results will be 
against the same infection in another animal species.  In our experi- 
ence, both Tr. evansi  and Tr. equiperdum are more easily dealt with 
in rats than in mice, a condition the reverse of which usually obtains.  1 
Principles of Adaptation and Utilization; Conclusions. 
We  have  endeavored  to show that the use of experimental tryp- 
anosomiasis in chemotherapeutic experiments should  be  based  upon 
a clear conception of the experimental disease as it occurs in laboratory 
animals and that the use of one or another of the experimental infec- 
tions is not to be undertaken in a  haphazard fashion but that there 
are definite principles upon which the experiments may be based. 
These  considerations  may  appear  obvious,  but  as  one  searches 
through  reports  dealing  with  experimental  chemotherapy of  tryp- 
anosomiasis, it  is  impossible  to  find  any clear-cut  application,  or 
even  recognition of  these principles  as  a  whole,  to  the problem  of 
chemotherapy.  Some have emphasized one point and some another, 
but on the whole, the problem of adaptation has been conceived with 
a very limited regard for the principles set forth.  In the first place, 
one must know the behavior of the various species of trypanosomes in 
the  animal body,  the  character  of the infection produced,  and  the 
response which may be expected from these organisms to the particular 
1  In speaking of drug resistance of different species or strains of trypanosomes, 
the phenomenon of drug fastness should be called to mind.  The differentiation 
between natural and acquired resistance or fastness to drug action is extremely 
difficult and since so much experimental work has been done with the various 
laboratory strains of trypanosomes, it is now almost impossible to say whether 
the resistance to drug action exhibited by any of these organisms is natural re- 
sistance or one which has resulted from laboratory handling. 142  EXPERIMENTAL  TRYPANOSOMIASIS 
class of therapeutic agents to be employed, and further than this, one 
must know even the peculiarities of the particular strain to be used. 
It is of equal importance also  that one should be familiar with the 
various factors which may influence these reactions and  the means 
to be employed to insure constancy of reaction under all circumstances. 
Finally, one should realize clearly the limitations to the usefulness of 
any particular form of the experimental infection or species of tryp- 
anosome as well as the limitations to deductions which may be drawn 
from all classes of experiments. 
The animal factor divides experimental trypanosomiasis of labora- 
tory animals into two main classes:  the acute blood infections of mice 
and rats and the chronic tissue infections of guinea pigs and rabbits. 
From the point of view of the chemotherapy of experimental trypano- 
somiasis, these two types of infection present totally different problems. 
Treatment of the acute infections of mice and rats is essentially one 
of speed, since the duration of the disease is but a matter of days and 
resolves itself into the treatment of a condition analogous to a bactere- 
mia in which the multiplying parasites are predominatingly found in 
the circulating blood.  A uniform and constant grade of infection is 
usually easily regulated in mice and rats and since relapses generally 
occur within 2  weeks after treatment, the more remote therapeutic 
effects are not delayed.  On  the other hand,  certain factors of im- 
portance which are not included in the infection of mice and rats are 
supplied  by  trypanosomiasis  of  guinea  pigs  and  rabbits.  In  the 
natural disease of human beings and of animals, tissue involvement is 
a conspicuous feature and the question of tissue penetrability must be 
taken into  account.  In experimental trypanosomiasis of the rabbit 
and of the guinea pig to a  somewhat less extent, tissue involvement 
with the consequent clinical signs and symptoms predominates and 
the use of these animals directly supplies the necessary experimental 
conditions which are wanting in the infections of mice and rats.  Not 
~only have the parasites to be killed by the therapeutic agent in treat- 
ing rabbit trypanosomiasis, but the involved tissue, the site of patho- 
logical  changes produced  by  the  invading  trypanosomes,  must  be 
penetrated  by  the  trypanocidal  substance,  and  furthermore,  the 
lesions themselves must be healed.  In addition, the factor of duration 
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practical outcome of the chemotherapeutic problem,  since trypan0- 
somiasis of human beings and of most animals is essentially a chronic 
rather than an acute disease, lasting weeks, months, and even years. 
Emphasis should also be laid on the individuality and irregularity of 
rabbit  and  guinea pig  trypanosomiasis which adds  considerably to 
the 'value of these animals in any extensive therapeutic experiments. 
The treatment of infected rabbits  especially, resolves itself into the 
treatment  of individuals  and  such  a  plan  of procedure is  directly 
comparable with that pursued in dealing with th~ naturally acquired 
disease.  As Strong and Teague (32) have pointed out in their paper 
on  the  treatment  of  surra  in  the  Philippine  Islands,  the methods 
of  treatment that  have given satisfactory results  in  mice and  rats 
have failed  to  cure  larger  animals.  In  order,  therefore,  to  repro- 
duce,  with  the  usual  laboratory  facilities,  experimental  conditions 
analogous  to  the  natural  infections  of man  and  animals,  we  have 
utilized the rabbit as the animal that most nearly fulfills the desired 
requirement  s .  From this point of view, the results of treatment of 
chronic tissue infections are indicative of curative power or therapeu- 
tic potency as contrasted with trypanocidal action. 
The selection of the species of trypanosomes should be based on 
knowledge of the type and  course of the infection produced in  the 
various  animal  species and  on  its  general resistance  to  therapeutic 
agents.  The virulence of any particular strain is dependent largely 
on its inherent natural qualities but may be measurably influenced by 
certain extraneous factors such as the length of time of isolation and 
the method of propagation,  which are subject to  the control of the 
investigator. 
Treatnlent  of  experimental  trypanosomiasis  of  mice  and  rats  i~ 
largely a  matter of speed of action.  Since these animals are easily 
procurable  and the results of treatment are quickly seen, the chemo- 
therapist  has  in this  type of infection a  valuable experimental test 
for  the  quick  determination of the  therapeutic activity of a  com- 
pound.  For all preliminary routine work, especially if a large  num- 
ber of compounds are to be tested, the utilization of mouse and rat 
infections  gives  definite  and  valuable  information  in  a  relatively 
short space of time.  On the other hand, since experimental trypano- 
somiasis of guinea pigs and rabbits is predomina~ely a  chronic tisst~e 144  EXPERIMENTAL TRYPANOSOMIASIS 
infection more nearly analogous to the naturally acquired forms of the 
disease,  the factor of ultimate  curative power or potency of a  com- 
pound, rather than its immediate trypanocidal action, is emphasized 
in the treatment of such infections.  From  the point of view of the 
chemotherapist,  the  two  types  of infections  supplement  each  other 
and the proper utilization and adaptation of each type constitute a 
logical  basis  for  procedure  in  the  chemotherapy  of  experimental 
trypanosomiasis. 
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EXPLANATION OF PLATES. 
PLATE 4. 
FIG. i.  Tr.  equiperdum.  Chronic  infection.  There  is loss of hair  about  the 
eye and over the nose and right lip.  The skin in  these  areas is thickened  and 
scaly. 
FIG. 2.  Tr. equiperdum.  Chronic infection.  There is loss of hair over a large 
area of the back, haunches,  and legs with marked thickening and scaling of the 
skin.  The anus, testicles, and prepuce are greatly enlarged and indurated. 
PLATE 5. 
FI6.3.  Tr. brucei.  Very early infection.  The upper eyelid is slightly swollen 
and puffy. 
FIG. 4.  Tr.  brucei.  Early  infection.  Both  upper  eyelids  are  very  swollen 
and the eyes are partially closed.  The base of the right ear is similarly  involved 
and the ear is beginning to droop. 
PLATE 6. 
FIG. 5.  Tr.  equinum.  Moderately advanced infection.  The  eye is partially 
closd, the face is swollen, crusts are beginning to form over the nose, and  the 
ears are partly drooping. 
FIG. 6.  Tr.  brucei.  Moderately advanced  infection.  The  eye  is  completely 
closed and the face between the eyes and over the bridge of the nose is swollen. 
PLATE 7. 
FIG. 7. Tr. brucei.  Early infection.  The left ear is swollen and thickened 
about the base and is hanging down. 
FIG. 8.  Tr.  brucei.  Moderately  advanced  infection.  The  condition  of  the 
left ear has increased and the right ear has become involved.  Both upper eyelids 
are swollen and the left eye is partially closed.  The face and lips are considerably 
swollen. 146  EXPERIMENTAL  TRYPANOSOMIASIS 
PLATE 8. 
FIG. 9.  Tr.  brucei.  Early infection.  The  left ear is slightly swollen  and  is 
beginning to droop. 
FIG. 10.  Tr.  brucd.  Moderately advanced infection.  The  right  ear droops, 
the right eye is almost closed, there is marked puffiness of the upper eyelid, and 
the face is swollen. 
PLATE 9. 
FIG. 11.  Tr.  brucei.  Moderately advanced infection.  The left lip is swollen 
and enlarged.  The left ear shows a toss of hair with scab formation of the skin 
along its outer margin. 
FIG. 12.  Tr.  brucei.  Early infection.  The entire face is very much  swollen, 
the lips slightly so.  Eyelids and ears are not yet involved. 
PLATE 10. 
FIG. 13.  Tr. brucei.  Advanced infection.  There is loss of hair together with 
an extensive scab formation along the outer margin of the left ear.  Both ears 
hang down.  (The left was held up in order that  the picture might be taken.) 
The left eye is almost closed and there is marked swelling of the face. 
FIG. 14.  Tr.  brucei.  Moderately advanced  infection.  There  is  an extensive 
scab formation with loss of hair about the base of the left ear extending ~p along 
the outer surface and margin.  The face over the bridge of the nose is somewhat 
swollen. 
PLATE 11. 
FIG. 15.  Tr.  brucei.  Early  infection.  Both  testicles  are  swollen,  the  left 
especially so. 
FIG. 16.  Tr.  gambiense.  Early  infection.  The  right  testicle  is  enormously 
swollen, the left slightly so.  The scrotum is very tense. 
FIo. 17.  Tr.  gambiense.  The  same  rabbit as in Fig.  16,  4  days later.  The 
right testicle is decreased somewhat in size and the left is now practically the same 
size.  The  scrotum  has  become indurated  and  brawny  and  on  the  right  side, 
there is a  superficial ulcer. 
FIG. 18.  Tr.  brucei.  Advanced  infection.  Both  testicles  are  larger  than 
normal and are exceedingly hard.  The scrotum has become thickened and indu- 
rated.  The prepuce is slightly swollen and is indurated. 
PLATE 12. 
FIG. 19.  Tr. brucel.  Early infection.  Moderate swelling and induration of the 
prepuce. 
FIG. 20.  Tr. brucei.  Advanced infection.  Extreme  swelling, induration,  and 
ulceration of the prepuce.  Moderate involvement of the testicles. LOUISE  PEARCE  AND  WADE  H.  BROWN  147 
FIG. 21.  Tr.  brucei.  Advanced  infection.  Swelling  and  induration" of  the 
penis and right testicle.  The left testicle is slightly affected.  Prepflce not in- 
volved. 
FIG.  22. Tr. brucei.  Moderatcly advanced infection. Swelling  and induration 
of  the  vulva  and anus. 
PLATE 13. 
FIG. 23.  Tr. brucei.  Advanced infection.  Marked lesions of eyes, ears, face, 
and nose with thick crusts about nose and lips.  There is a profuse purulent dis- 
charge. 
FIG. 24.  Tr.  brucd.  Advanced infection.  The face is swollen and indurated 
and the eyelids are glued together with a purulent exudate.  The base of the left 
ear  is  affected. 
PLATE 14. 
FIG. 25.  Tr.  brucd.  Advanced  infection.  Marked  general  emaciation  with 
few local signs.  The eyelids and face are slightly swollen. 
PLATE 15. 
FIG. 26.  Tr. brucei.  Chronic infection.  Loss of hair over face, nose, and about 
the eyes.  The  underlying skin is indurated and  has lost its normal elasticity. 
Scab formation about  the eyes. 
FIG. 27.  Tr. brucei.  Chronic infection.  Necrosis of the soft and hard parts 
over the bridge of the nose.  Moderate involvement of the eyelids and base of 
ears. 
FIG. 28.  Tr.  brucd.  Long  standing,  chronic  infection.  Extreme  necrosis of 
face,  nose,  and lips with  secondary infection.  Marked  involvement of eyelids 
and ears. 
PLATE 16. 
FXa. 29.  Tr.  breed.  Chronic  infection.  Loss  of  hair  with  induration  and 
scaling of the skin along the hind leg. 
FIG. 30.  Tr. b~ucei.  Chronic infection.  Loss of hair, induration of the skin, 
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